EA
GILD icon

Euclid Advisors’s Gilead Sciences GILD Stock Holding History

Euclid Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-137,350
Closed -$11.5M – 197
2016
Q2 		$11.5M Sell
137,350
-7,745
-5% -$687K 0.5% 55
2016
Q1 		$13.3M Sell
145,095
-76,697
-35% -$6.92M 0.5% 52
2015
Q4 		$22.4M Buy
221,792
+129,792
+141% +$13.5M 0.69% 32
2015
Q3 		$9.03M Sell
92,000
-248,745
-73% -$27.6M 0.41% 85
2015
Q2 		$39.9M Sell
340,745
-313,825
-48% -$34.3M 0.79% 32
2015
Q1 		$64.2M Buy
+654,570
New +$66.5M 1.18% 14
2014
Q4 		– Sell
-769,310
Closed -$81.9M – 428
2014
Q3 		$81.9M Buy
769,310
+39,930
+5% +$3.91M 0.59% 28
2014
Q2 		$60.5M Sell
729,380
-288,652
-28% -$22.5M 0.42% 43
2014
Q1 		$72.1M Buy
1,018,032
+240,700
+31% +$18.9M 0.54% 35
2013
Q4 		$58.4M Sell
777,332
-43,020
-5% -$3M 0.48% 39
2013
Q3 		$51.6M Buy
820,352
+55,992
+7% +$3.35M 0.52% 39
2013
Q2 		$39.1M Buy
+764,360
New +$39.8M 0.49% 43

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Euclid Advisors's GILD Position: Q3 2016 in Review

Euclid Advisors sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 137,350 shares — an estimated $11.5M sold.

Euclid Advisors first reported a position in GILD in Q2 2013 and held it in 12 quarters. The position peaked at $81.9M in Q3 2014. 1,558 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • Euclid Advisors reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 137,350 Gilead Sciences shares in Q3 2016, an estimated $11.5M.
  • Euclid Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 12 quarters.
  • Euclid Advisors's Gilead Sciences position peaked at $81.9M in Q3 2014.
  • 1,558 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.